Results 181 to 190 of about 143,935 (260)

Latviešu Ārstu un Zobārstu Apvienības goda biedra profesora Dr. med. Jēkaba Alkšņa dzīves gaita

Acta Medico-Historica Rigensia, 1999
AML Medicīnas vēstures institūts
doaj   +1 more source

Real-world, multi-omics validation of the clinical relevance of molecular taxonomy for myelodysplastic syndromes (MDS). [PDF]

Hemasphere
Maggioni G, Todisco G, Sauta E, Lanino L, Ball S, Bewersdorf JP, Kewan T, Al Ali NH, Fenaux P, Platzbecker U, Santini V, Xie Z, Brunner AM, Kuykendall AT, Bennett JM, Buckstein R, Bejar R, Carraway HE, DeZern AE, Griffiths EA, Halene S, Hasserjian RP, List AF, Loghavi S, Odenike O, Padron E, Patnaik MM, Roboz GJ, Stahl M, Sekeres MA, Steensma DP, Savona MR, Taylor J, Xu ML, Sallman DA, Nimer SD, Hourigan CS, Wei AH, Campagna A, Ubezio M, Riva E, Ventura D, Pinocchio N, Zampini M, Buizza A, Russo A, Pesce F, D'Amico S, Asti G, Delleani M, Travaglino E, Tentori CA, Ferrari I, Crespi A, Figini G, Di Matteo M, Brindisi M, Manes N, Milanesi C, Crisafulli L, Ficara F, Castellani G, Borate UM, Efficace F, Gore SD, Kim TK, Diez-Campelo M, van de Loosdrecht AA, Daver N, Rozman M, Orfao A, Wang SA, Foucar K, Iastrebner M, Scheinberg P, Miyazaki Y, Madanat YF, Al-Kali A, Mittelmann M, Cluzeau T, Ades L, Germing U, Garcia-Manero G, Kordasti S, Haferlach T, Zeidan AM, Komrokji RS, Della Porta MG, An international study on behalf of GenoMed4all, Synthema, and icMDS consortia.   +90 more
europepmc   +1 more source

What is the best path towards allogeneic transplantation in MDS and AML? A survey among German-spreaking centers for allogeneic hematopoietic stem cell transplantation. [PDF]

Ann Hematol
Krause SW, Bethge W, Bug G, Elmaagacli A, Jost E, Klein SA, Kobbe G, Kraus S, Krüger WH, Luft T, Müller LP, Schäfer-Eckart K, Schetelig J, Steiner N, Stelljes M, Tischer J, Winkler J, Wolff D, Wortmann F, Röllig C.   +19 more
europepmc   +1 more source

Therapeutic potential of natural products in cancer immunotherapy: Advances and challenges

British Journal of Pharmacology, EarlyView.
This review systematically outlines the mechanisms underlying tumour immunotherapy resistance and elucidates the role of natural products in enhancing therapeutic efficacy as immunomodulatory adjuvants. Abstract Immunotherapy has emerged as a clinically pivotal approach in cancer treatment, but its application remains limited to a small subset of ...
Rao Hu, Kaibin Dai, Zhensheng Lin, Mingfang Ye, Minfeng Chen, Xiaobo Li, Dongmei Zhang   +6 more
wiley   +1 more source

Validation of ICC hierarchical classification in secondary AML. [PDF]

Blood Adv
Attardi E, Cipriani M, Guarnera L, Savi A, Fabiani E, Mallegni F, Moretti F, Silvestrini G, Awada H, Durmaz A, Ferrari I, Maggioni G, Memoli M, Visconte V, Venditti A, Della Porta MG, Gurnari C, Piciocchi A, Maciejewski JP, Voso MT.   +19 more
europepmc   +1 more source

Targeting KRAS for cancer therapy

British Journal of Pharmacology, EarlyView.
In recent years, therapeutics targeted against KRAS proto‐oncogene GTPase (KRAS)‐mutant cancers have seen significant progress. Herein we outline the biology and epidemiology of KRAS alterations at the lineage and allele levels, reviewing the clinical evidence for KRASG12C inhibition from the discovery of the recessive switch pocket to sotorasib ...
Jianlong Jia, Ruonan Liu, Tonia A. Adamide, Isis E. Fernandez, Georgios T. Stathopoulos   +4 more
wiley   +1 more source

Elevated Allele Frequency of a Common Germline <i>LAG3</i> Variant Associated with Anemia, Thrombocytopenia and Peripheral Blast Percentage in Acute Myeloid Leukemia. [PDF]

Cancers (Basel)
Seipel K, Shaforostova I, Tarozzi E, Kronig MN, Bacher U, Pabst T.   +5 more
europepmc   +1 more source

[Genetic alterations in AML].

[Rinsho ketsueki] The Japanese journal of clinical hematology, 2013
openaire   +2 more sources

CD93—An emerging vascular target in cancer therapy

British Journal of Pharmacology, EarlyView.
Abstract CD93 is a single‐pass transmembrane glycoprotein that belongs to the C‐type lectin domain group XIV family of proteins. Although it is known to be expressed in other cell types, namely, in some subsets of immune cells, CD93 is primarily expressed on endothelial cells, where it acts as a crucial regulator of angiogenesis.
Beatriz de Alves Pereira, Stefano Barbera, Roberta Lugano, Anna Dimberg   +3 more
wiley   +1 more source